1 eliminate HIV-1 proviruses from the chromosomes of long-lived CD4 + memory T 2 cells. To escape eradication by these antiviral drugs, or by the host immune 3 system, HIV-1 exploits poorly defined host factors that silence provirus 4 transcription. These same factors, though, must be overcome by all retroviruses, 5 including HIV-1 and other primate immunodeficiency viruses, in order to activate 6 provirus transcription and produce new virus. Here we show that Vpx and Vpr, 7 proteins from a wide range of primate immunodeficiency viruses, activate 8 provirus transcription in human CD4 + T cells. Provirus activation required the 9 DCAF1 adaptor that links Vpx and Vpr to the CUL4A/B ubiquitin ligase complex, 10 but did not require degradation of SAMHD1, a well-characterized target of Vpx 11 and Vpr. A loss-of-function screen for transcription silencing factors that mimic 12 the effect of Vpx on provirus silencing identified all components of the Human 13 Silencing Hub (HUSH) complex, FAM208A (TASOR/RAP140), MPHOSPH8 (MPP8), 14 PPHLN1 (PERIPHILIN), and MORC2. Vpx associated with the HUSH complex 15 components and decreased steady-state levels of these proteins in a DCAF-16 dependent manner. Finally, vpx and FAM208A knockdown accelerated HIV-1 and 17 SIV MAC replication kinetics in CD4 + T cells to a similar extent, and HIV-2 replication 18 required either vpx or FAM208A disruption. These results demonstrate that the 19 HUSH complex restricts transcription of primate immunodeficiency viruses and 20 thereby contributes to provirus latency. To counteract this restriction and 21 activate provirus expression, primate immunodeficiency viruses encode Vpx and 22 Vpr proteins that degrade HUSH complex components. 23 2017), whose demonstration that cells may carry Rous sarcoma virus genetic 479 information in the absence of any infectious virus production provided support to the 480 proviral hypothesis. We thank Lisa Cavacini for anti-CD3 and anti-CD28 antibodies, and 481 Akio Adachi and Mikako Fujita for pGL-St and pGL-An. The following reagents were 482 obtained through the AIDS Reagent Program, Division of AIDS, NIAID, NIH: J-Lat Tat-483
When provided in trans, many primate immunodeficiency virus Vpx and Vpr orthologues 24 increase HIV-1 reverse transcription and transduction efficiency in dendritic cells, 25 macrophages, and resting CD4 + T cells (Baldauf et al., 2012; ; Goujon et al., 2006; ; Lim et 26 al., 2012; ; Sharova et al., 2008; ; Srivastava et al., 2008) . As substrate adaptor proteins 27 for the DCAF1-CUL4A/B E3 ubiquitin ligase, Vpx and Vpr increase the concentration of 28 deoxynucleotide triphosphate (dNTP) levels in target cells by degrading the 29 deoxynucleotidetriphosphate (dNTP) hydrolase SAMHD1 (Hrecka et al., 2011; ; Laguette 30 et al., 2011; ; Lim et al., 2012) . Nonetheless, Vpx and Vpr have additional effects on 31 expression of transduced reporter genes that are not explained by SAMHD1 32 degradation or by increase in dNTP concentration (Goh et al., 1998; ; Miller et al., 2017; ; 33 Pertel et al., 2011a; ; Reinhard et al., 2014) . 34 To better understand the effect on provirus reporter gene expression, vpx was 35 introduced before, during, or after transduction of a reporter gene (Fig.  1a ). Jurkat CD4 + 36 T cells were transduced with a dual-promoter, lentiviral vector that expresses codon-37 optimized SIV MAC 251 vpx from the spleen focus forming virus (SFFV) promoter and 38 puromycin acetyltransferase (puro R ) from the PPIA (CypA) promoter (Neagu et al., 39 2009;; Reinhard et al., 2014) (Lenti 1 in the Fig.  1a time-line, Supplementary  Fig.  1a , and 40 Supplementary Table 1 ). A control Lenti 1 vector was used that lacks vpx 41 ( Supplementary Fig. 1a ). Puromycin was added to the culture on day three to select 42 those cells that had been transduced with Lenti 1. On day seven, cells were transduced 43 with a second lentivector bearing a codon-optimized gag-gfp reporter gene expressed 44 from the SFFV promoter, as well as SIV MAC 251 vpx expressed from the CypA promoter 45 (Lenti 2 in the Fig.  1a timeline and Supplementary  Fig.1a ). A control Lenti 2 vector was 3 used that lacks vpx ( Supplementary Fig.1a ). On day ten, virus-like particles (VLPs) 47 containing Vpx protein were added to the twice-transduced cells (Fig.  1a ). As controls, 48 VLPs lacking Vpx were used, or no VLPs were added. On day fourteen, the percent 49 GFP + cells under each condition was assessed by flow cytometry using standard gating 50 for viable, singlet, lymphoid cells ( Supplementary Figure 1b) . Vpx increased the 51 percentage of GFP + cells, whether vpx was transduced before, or concurrent with, 52 reporter gene transduction, or if Vpx protein was delivered by VLPs after reporter gene 53 transduction ( Fig. 1b and Supplementary Fig 1c; ; n=3 biological replicates, p<0.02, 1-54 way ANOVA with Dunnett post-test). These results suggest that the transduced reporter 55 gene was actively silenced and that vpx overcame reporter silencing. 56 To confirm that the findings in Fig. 1b were due to effects of vpx on 57 transcriptional silencing of the reporter gene, and not due to effects on transduction 58 efficiency, Jurkat T cells were first transduced with a vector in which the gag-gfp 59 reporter gene was expressed from the SFFV promoter and blasticidin-S deaminase 60 (blasti R ) was expressed from the CypA promoter. Four days after transduction with the 61 reporter vector and selection with blasticidin, cells were either challenged with Vpx + 62 VLPs, or transduced and selected with the dual-promoter lentivector encoding vpx and 63 puroR (Lenti 1 in Supplementary Fig. 1a ). Four days later the GFP signal was at 64 background levels unless Vpx was provided, either by VLPs (Fig. 1c ) or by vpx 65 transduction (Fig.  1d ). The effect of vpx on reporter gene expression was confirmed by 66 qRT-PCR for the reporter mRNA ( Supplementary  Fig.  1d ). Reporter gene silencing and 67 reactivation by Vpx was not specific to the SFFV promoter since GFP signal was similar 68 when the reporter gene was expressed from the human EEF1A1 (EF1α) promoter or 69 from the Herpes simplex virus type 1 thymidine kinase (TK) promoter (Supplementary 70 Fig.  1e ). These results demonstrate that Vpx overcomes transcriptional silencing of the 71 provirus. 72 To determine if the ability to activate transcription of silenced proviruses is 73 peculiar to SIV MAC 251 Vpx, representative Vpx and Vpr orthologues, selected from 74 across the phylogeny of primate immunodeficiency viruses, were examined. All Vpx 75 proteins tested, SIV DRL D3, SIV RCM NG411, SIV AGI 00CM312, SIV RCM 02CM8081, 76 SIV MND2 5440, HIV-2 ROD , SIV MAC 251, and SIV MNE 027, had transactivating activity in 77 human cells ( Fig.  1e and Supplementary  Fig  1f) . Conservation of this activity in human 78 cells among such divergent SIV orthologues was surprising given that SIV RCM NG411 79 Vpx and SIV MND2 5440 Vpx do not degrade human SAMHD1, but they do degrade the 80 SAMHD1 orthologue from their cognate primate host species (Lim et al., 2012) . Several 81 Vprs from SIVs that lack Vpx, including SIV MUS2 CM1246, SIV AGM Ver9063, SIV AGM TAN1, 82 SIV MND1 GB1, and SIV LST 524, also activated transcription of silent proviral reporters in 83 human cells ( Fig. 1e and Supplementary Fig. 1f ). Results could not be obtained from 84 this experimental system concerning the activity of Vprs encoded by SIV CPZ TAN3, HIV-85 1 U14788 (Group P), SIV GOR CP684con, HIV-1 MVP5180 (Group O), HIV-1 NL4-3 (Group M), 86 SIV CPZ LB7, and SIV RCM 02CM8081, presumably because these orthologues caused cell 87 cycle arrest and toxicity (Chang et al., 2004; ; Goh et al., 1998; ; He et al., 1995; ; Re et al., 88 1995) (indicated by ∅ in Fig.  1e ). Vpx and Vpr sequence variability is among the highest 89 observed for lentiviral coding sequences (McCarthy and Johnson, 2014) ;; the sequences 90 shown in Fig.  1e have an average amino acid identity of only 27%. Such diversity likely 91 reflects rapidly evolving, host-pathogen interfaces (Fregoso et al., 2013) , and precluded 5 activity predictions based on amino acid sequence conservation to guide the 93 engineering of loss-of-function mutations. 94 To gain insight into the mechanism by which Vpx overcomes transcriptional 95 silencing of lentiviral transgenes, a loss-of-function screen was performed focusing on 96 genes reported to contribute to silencing of retroviruses and other transcriptional targets 97 (Chéné et al., 2007; ; Peterlin et al., 2017; ; Tchasovnikarova et al., 2015 ; Tchasovnikarova et al., , 2017 ; Wang and 98 Goff, 2017; ; Weinberg and Morris, 2016; ; Wolf and Goff, 2007) . Jurkat T cells were 99 transduced with lentivectors that confer puromycin resistance and express shRNAs 100 (Pertel et al., 2011b) targeting either AGO1, AGO2, AGO3, DNMT3A, HDAC1, HP1, 101 SUV39H1, SUV39H2, PIWIL2, TRIM28, SETDB1, FAM208A, MPHOSPH8, PPHLN1, or 102 MORC2. After selection for five days with puromycin, cells were transduced with the 103 Lenti 2 gag-gfp reporter vector without vpx ( Supplementary  Fig.  1a ). Four days later, the 104 change in expression of the gfp reporter due to the knockdowns was calculated as a 105 percentage of the activity observed in a separate population of Jurkat cells transduced 106 to express vpx ( Fig. 2a ). A given gene was implicated as a transcriptional silencing 107 factor for the provirus reporter gene if the three shRNA targets for that gene differed 108 significantly from that of the luciferase knockdown control (p<0.05, 1-way ANOVA with 109 Dunnett post-test). shRNAs targeting each of the three core components of the Human 110 Silencing Hub (HUSH) complex, FAM208A, MPHOSPH8, and PPHLN1, increased 111 reporter gene expression ( Fig.  2a ).
112
The effect on reporter gene expression in Jurkat T cells of the most effective 113 shRNA target sequences for FAM208A, MPHOSPH8, and PPHLN1 is shown in Fig.  2b . 114 The effectiveness of the knockdown of each of the HUSH complex components in 115 Jurkat cells was confirmed by immunoblotting lysate from these cells with antibodies 116 specific for FAM208A, PPHLN1, or MPHOSPH8 ( Fig. 2c ). As previously reported 117 (Tchasovnikarova et al., 2015) , knockdown of any individual HUSH complex component 118 caused a decrease in the level of each of the other components. Similar results on 119 reporter gene expression were obtained when FAM208A, MPHOSPH8, or PPHLN1 120 were knocked down in primary human CD4 + T cells ( Fig.  2d ). Knockdown of each of the 121 HUSH complex components, then, had the same effect as vpx on lentiviral reporter 122 gene expression ( Fig.  2b  and  d and Supplementary  Fig  2a) . These results demonstrate 123 that the HUSH complex is critical for provirus silencing and raise the possibility that Vpx 124 acts as a substrate adaptor targeting HUSH components to DCAF1 and the CUL4A/B 125 E3 ubiquitin ligase complex for degradation, in the same way that Vpx targets SAMHD1 126 (Hrecka et al., 2011; ; Laguette et al., 2011) . 127 To determine if Vpx promotes the degradation of HUSH complex components, 128 lysate from cells transduced to express SIV MAC 251, SIV MND2 5440, or SIV RCM NG411 vpx 129 was immunoblotted with antibodies specific for FAM208A, PPHLN1, or MPHOSPH8. All 130 three Vpx proteins reduced the steady-state level of all three core HUSH complex 131 components ( Fig.  2e ). Among the three HUSH components, though, FAM208A protein 132 levels were decreased more than the other two components ( Fig. 2h and Supplementary Figs. 2d,e ). 156 These results demonstrate that FAM208A associates with Vpx and that the interaction 157 results in proteasome-mediated degradation of FAM208A. Supplementary  Fig  3a) . (Fig.  4d ). This delay in SIV MAC 239-Δvpx replication kinetics was not observed when 219 FAM208A was knocked down (Fig.  4d ). Replication of HIV-2 GH Δvpx was undetectable in 220 control knockdown CEMx174 cells ( Fig. 4e ). However, FAM208A knockdown rescued 221 the replication of HIV-2 GH Δvpx to the level of wild-type HIV-2 GH in control cells (Fig.  4e ). 222 These experiments indicate that FAM208A inhibits primate immunodeficiency virus 223 replication and that Vpx antagonizes this restriction, resulting in expression -or 224 increased expression - from integrated proviruses, permitting virus spread. 225 The experiments reported here demonstrated that vpx and vpr activate 226 transcription from silenced proviruses and that this activity was mimicked by knockdown CD4 + T cells were activated for 3 days with PHA and then transduced and assayed as in (b). e, 521
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